IL99180A - צורות מינון לשיחרור מבוקר הניתנות לפירוק ביולוגי - Google Patents

צורות מינון לשיחרור מבוקר הניתנות לפירוק ביולוגי

Info

Publication number
IL99180A
IL99180A IL99180A IL9918091A IL99180A IL 99180 A IL99180 A IL 99180A IL 99180 A IL99180 A IL 99180A IL 9918091 A IL9918091 A IL 9918091A IL 99180 A IL99180 A IL 99180A
Authority
IL
Israel
Prior art keywords
polymer
active agent
pharmacologically active
dosage form
ivermectin
Prior art date
Application number
IL99180A
Other languages
English (en)
Other versions
IL99180A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL99180A0 publication Critical patent/IL99180A0/xx
Publication of IL99180A publication Critical patent/IL99180A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
IL99180A 1990-08-22 1991-08-14 צורות מינון לשיחרור מבוקר הניתנות לפירוק ביולוגי IL99180A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57074290A 1990-08-22 1990-08-22

Publications (2)

Publication Number Publication Date
IL99180A0 IL99180A0 (en) 1992-07-15
IL99180A true IL99180A (he) 1998-01-04

Family

ID=24280874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99180A IL99180A (he) 1990-08-22 1991-08-14 צורות מינון לשיחרור מבוקר הניתנות לפירוק ביולוגי

Country Status (13)

Country Link
US (1) US5837228A (he)
EP (1) EP0473223B1 (he)
JP (1) JP2588328B2 (he)
AT (1) ATE122230T1 (he)
AU (1) AU645594B2 (he)
CA (1) CA2049668C (he)
DE (1) DE69109581T2 (he)
DK (1) DK0473223T3 (he)
ES (1) ES2072530T3 (he)
IE (1) IE67141B1 (he)
IL (1) IL99180A (he)
NZ (1) NZ239370A (he)
PT (1) PT98708B (he)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
ES2258495T3 (es) * 1994-04-08 2006-09-01 Qlt Usa, Inc. Composiciones de administracion liquida de farmacos.
CA2304283A1 (en) * 1997-09-23 1999-04-01 Pfizer Limited Parasiticidal formulations
US6524602B1 (en) * 1998-10-13 2003-02-25 Craig G. Burkhart Polymer delivery system in treatments for parasitic skin diseases
CN1244684C (zh) * 1999-03-11 2006-03-08 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
DE60131177T2 (de) 2000-09-06 2008-08-07 AP Pharma, Inc., Redwood Abbaubare polyacetal-polymere
CA2429898C (en) * 2000-11-16 2011-02-22 Durect Corporation Devices and methods for cholesterol management
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US20040142902A1 (en) * 2001-11-08 2004-07-22 Struijker- Boudier Harry A.J. Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7288609B1 (en) * 2003-03-04 2007-10-30 Advanced Cardiovascular Systems, Inc. Coatings for drug delivery devices based on poly (orthoesters)
EP1626748B1 (en) * 2003-05-13 2012-07-11 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
EP2044142A2 (en) 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
JP2012512163A (ja) * 2008-12-11 2012-05-31 エーピー ファーマ， インコーポレイテッド ポリオルトエステルおよびそれらの製剤の安定性を高めるための方法
JP5981430B2 (ja) * 2010-07-30 2016-08-31 セヴァ サンテ アニマレＣｅｖａ Ｓａｎｔｅ Ａｎｉｍａｌｅ ハートワーム感染を治療するための組成物
EP2608660B1 (en) * 2010-07-30 2020-04-01 Ceva Sante Animale Compositions for treating heartworm infestation
BR122020002199B1 (pt) 2011-12-02 2021-01-19 Merial, Inc. formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4150108A (en) * 1975-12-29 1979-04-17 Graham Neil B Injectable medicinal compositions
EP0000291B1 (en) * 1977-06-28 1981-09-30 University of Strathclyde A pharmaceutical composition for tropical diseases
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4304767A (en) * 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4636387A (en) * 1982-06-21 1987-01-13 Research Corporation Anesthetic polyorganophosphazenes
US4639366A (en) * 1984-06-06 1987-01-27 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4765973A (en) * 1984-06-06 1988-08-23 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4764764A (en) * 1984-11-27 1988-08-16 Honeywell Inc. Write-protect apparatus for bit mapped memory
CS254355B1 (en) * 1985-04-10 1988-01-15 Vladimir Saudek Soluble and biodegradatable copolymeres activated for bond of biologicaly active substances
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
WO1989005138A1 (en) * 1987-12-08 1989-06-15 Mark Chasin Method of forming bioerodible implants for improved controlled drug release

Also Published As

Publication number Publication date
CA2049668C (en) 2002-11-12
IE67141B1 (en) 1996-03-06
NZ239370A (en) 1994-04-27
AU8267891A (en) 1992-02-27
EP0473223B1 (en) 1995-05-10
ATE122230T1 (de) 1995-05-15
ES2072530T3 (es) 1995-07-16
DK0473223T3 (da) 1995-07-10
US5837228A (en) 1998-11-17
PT98708B (pt) 1999-01-29
PT98708A (pt) 1992-08-31
DE69109581D1 (de) 1995-06-14
EP0473223A1 (en) 1992-03-04
JPH04230621A (ja) 1992-08-19
JP2588328B2 (ja) 1997-03-05
IE912965A1 (en) 1992-02-26
DE69109581T2 (de) 1996-01-18
IL99180A0 (en) 1992-07-15
CA2049668A1 (en) 1992-02-23
AU645594B2 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
US5837228A (en) Bioerodible implants
US5211951A (en) Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
US5176907A (en) Biocompatible and biodegradable poly (phosphoester-urethanes)
US6984393B2 (en) Biodegradable elastomer and method of preparing same
Kitchell et al. [32] Poly (lactic/glycolic acid) biodegradable drug—polymer matrix systems
US4882168A (en) Polyesters containing alkylene oxide blocks as drug delivery systems
EP0635272B1 (en) Liquid absorbable copolymers for parenteral applications
US4130639A (en) Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
EP0258780B1 (en) Polyesters containing alkylene oxide blocks as drug delivery systems
HU186904B (en) Process for producing retarde pharmaceutical compositions
KR20100120243A (ko) 약물 전달 장치를 형성하는 공정
Heller et al. Use of poly (ortho esters) for the controlled release of 5-fluorouracyl and a LHRH analogue
WO2003009833A1 (en) Sustained release delivery system
US5538738A (en) Retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material
AU2014203350A1 (en) Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue
EP1458352A1 (en) Solid dose micro implant
US5254345A (en) Poly(orthocarbonate acetal) bioerodible polymers
KR20050007377A (ko) 약물 전달 장치를 형성하는 공정
AU3176999A (en) Sustained release formulation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees